Regencell Bioscience Holdings (Regencell Bioscience Holdings) Issuance of Debt : $0.00 Mil (TTM As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Regencell Bioscience Holdings Issuance of Debt?

Regencell Bioscience Holdings's Issuance of Debt for the six months ended in Jun. 2023 was $0.00 Mil.

Regencell Bioscience Holdings's Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00 Mil.

Regencell Bioscience Holdings Issuance of Debt Historical Data

The historical data trend for Regencell Bioscience Holdings's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regencell Bioscience Holdings Issuance of Debt Chart

Regencell Bioscience Holdings Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

Issuance of Debt

0.48

0.99

0.61

Regencell Bioscience Holdings Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Issuance of Debt	Get a 7-Day Free Trial				0.14	-	-	-	-

Regencell Bioscience Holdings Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

Regencell Bioscience Holdings Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Regencell Bioscience Holdings's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Regencell Bioscience Holdings (Regencell Bioscience Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regencell Bioscience Holdings Ltd (NAS:RGC) » Definitions » Issuance of Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

29 Leighton Road, 9/F Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG

Website

https://www.regencellbioscience.com

Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.